Development :: TG03

Capoxigem
TG02
TG03
ProGEM™

TG03: Capoxigem + EGFR-TKI combination

TG03 is an oral, fixed dose product combining Capoxigem (apricoxib, TG01) with an EGFR tyrosine kinase inhibitor. This program is in preclinical development.

Terms of Use | Privacy Policy      2009 © Tragara Pharmaceuticals, Inc.